Neoadjuvant Docetaxel and Capecitabine in Patients With High Risk Prostate Cancer

Judah Friedman, Rodney L. Dunn, David Wood, Ulka Vaishampayan, Angela Wu, Deborah Bradley, James Montie, Fazlul H. Sarkar, Rajal B. Shah, Maha Hussain

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Neoadjuvant Docetaxel and Capecitabine in Patients With High Risk Prostate Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences